tiprankstipranks
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market
IONS
Ionis Pharmaceuticals
RESEARCH TOOLSreports

Ionis Pharmaceuticals (IONS) Income Statement

Compare
1,480 Followers

Ionis Pharmaceuticals Income Statement

Last quarter (Q4 2025), Ionis Pharmaceuticals's total revenue was $203.00M, a decrease of -10.41% from the same quarter last year. In Q4, Ionis Pharmaceuticals's net income was $-229.00M. See Ionis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 944.00M$ 705.14M$ 787.65M$ 587.37M$ 810.46M
Gross Profit
$ 928.00M$ 693.92M$ 778.51M$ 573.25M$ 799.61M
Operating Expenses
$ 1.31B$ 1.17B$ 1.13B$ 983.44M$ 829.80M
Depreciation and Amortization
$ 20.25M$ 21.99M$ 22.50M$ 22.11M$ 19.56M
EBITDA
$ -286.75M$ -353.72M$ -235.87M$ -227.76M$ -5.19M
Operating Income
$ -382.00M$ -475.08M$ -353.73M$ -410.19M$ -30.19M
Other Income/Expenses
$ 2.00M$ 15.01M$ 19.77M$ 152.21M$ 1.04M
Pretax Income
$ -380.00M$ -460.07M$ -333.96M$ -257.99M$ -29.15M
Net Income
$ -381.00M$ -453.90M$ -366.29M$ -269.72M$ -28.60M
Per Share Metrics
Basic EPS
$ -2.38$ -3.04$ -2.56$ -1.90$ -0.20
Diluted EPS
$ -2.38$ -3.04$ -2.56$ -1.90$ -0.20
Weighted Average Shares Outstanding
 160.00M 149.51M 143.00M 141.85M 141.02M
Weighted Average Shares Outstanding (Diluted)
 160.00M 149.51M 143.19M 141.85M 141.02M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History